PURPOSE: To facilitate the identification of genes associated with cataract and other ocular defects, we developed and validated a computational tool termed iSyTE (integrated Systems Tool for Eye gene discovery; http://bioinformatics.udel.edu/Research/iSyTE). iSyTE uses a mouse embryonic lens gene expression dataset as a bioinformatic filter to select candidate genes from human or mouse genomic regions implicated in disease, and to prioritize them for further mutational and functional analyses.
Even with the advent of high-throughput sequencing, the discovery of genes associated with congenital birth defects such as eye defects remains a challenge. We sought to develop a straightforward experimental approach that could facilitate the identification of candidate genes for developmental disorders, and as proof-of-principle, we chose defects involving the ocular lens. Opacification of the lens results in cataract, a leading cause of blindness that affects 77 million individuals and accounts for 48% of the blind. 1 Cataracts can be classified as either congenital or age-related, and can be expressed as either an "isolated", "non-syndromic" phenotype, or as part of a larger developmental syndrome. [2] [3] [4] Approximately one quarter of congenital cataracts are inherited, 5 and all three modes of Mendelian inheritance have been described, with autosomal dominant being the most common. 2 Both linkage and mutational analyses of candidate genes have been successfully used to identify genetic causes of congenital cataracts, and presently 24 loci exists for isolated cataracts. 2 The identification of genetic mutations -such as those implicated in cataract formationtraditionally follows an initial mapping step that involves linkage analysis or homozygosity mapping, followed by sequence analysis of candidate genes or genomic regions in patient DNA.
A similar approach can identify mutant genes in model organisms such as mouse and zebrafish.
Nonetheless, linkage and mutational analysis are cumbersome, and often involve the exclusion of a large number of candidate genes by DNA sequence analysis before the correct gene is identified. While the advent of next generation sequencing makes it possible to rapidly identify a large number of potentially deleterious genetic variants within a sample, it often remains unclear how to identify the actual disease-associated mutation in a cost-effective manner without performing a large cohort case-control study. It is often the case that additional biological knowledge is necessary to resolve disease-producing genetic mutations from sequence variants that are unrelated to the phenotype of interest.
In the case of human developmental disorders, we hypothesized that knowledge of embryonic gene expression patterns, which are often conserved and readily accessible for the homologous mouse genes, could help assist in the identification of congenital birth defect genes in human. Here we describe a straightforward experimental and computational strategy to identify and prioritize candidate disease genes based on microarray gene expression profiles that are generated from embryonic mouse tissues. As an initial application, we applied this to cataract phenotypes. To make this tool broadly accessible, we concurrently developed a publicly available web-based resource termed iSyTE (integrated Systems Tool for Eye gene discovery) that can efficiently prioritize candidate genes associated with human congenital cataract.
METHODS

Mouse Husbandry
Mice were treated in accordance with protocols established by the Association for Research in Vision and Ophthalmology (ARVO). The Animal Care and Use Committee (IACUC) of Harvard Medical School (Boston, MA) approved all experimental protocols involving mice.
Wild type ICR mice were obtained from Taconic (Albany, NY) and used for microarray and in situ hybridization analyses. Mice were housed in a 14 h light and 10 h dark cycle, and the morning of vaginal plug discovery was defined as embryonic day E0.5.
Microarray Analysis
Total RNA was extracted from manually dissected mouse embryonic day 10.5, 11.5 and 12.5 lenses (approximately 200 lenses per E10.5 replicate, 150 lenses per E11.5 replicate, 100 lenses per E12.5 replicate), or from whole embryonic tissue minus the eye region at stages E10.5, E11.5 and E12.5 using the RNeasy Mini Kit (Qiagen). RNA from stage matched whole embryonic tissue minus the eye region, which was removed by microdissection, was pooled in equimolar ratios, denoted the whole body or "WB" control, and was processed in parallel. Microarray data from the WB control was later used to achieve in silico enrichment for lens enriched genes (see Results). We first tested the purity of the dissected lens tissue by analyzing dissected lenses at these stages from P0-3.9-GFPCre reporter mice, in which the lens-specific GFP expression is driven by the Pax6 ectodermal enhancer within the 3.9-kb region upstream of the Pax6 P0 promoter. 6 We then used wild-type in house timed pregnant ICR mice as a resource for collecting the lens tissues that were used for microarray analysis. Microarray analyses were performed in biological triplicate by hybridization to the Affymetrix Mouse 430 2.0 chip in the Biopolymers facility at Harvard Medical School. Standard Affymetrix protocols were used to prepare cDNA and biotin labeled cRNA using in vitro transcription. Quality of the total RNA was evaluated via an Agilent 2100 Bioanalyzer prior to being processed for cDNA preparation by RT-PCR. The cDNA was converted to biotinylated cRNA using modified NTPs in an in vitro transcription reaction. The labelled cRNA was hybridized to the chips for 16 hr and then washed and stained. The chip was irradiated at 488 nm (excitation) and scanned at 570 nm (emission).
Raw probe intensities from all microarray profiles were preprocessed together using the robust multiarray average (RMA) method, 7 implemented in the affy package. 8 If a gene was represented by multiple probe sets, we selected the probe set with the highest median expression across all samples to represent the expression of that gene. In this manner, all probe sets were collapsed into 20,460 genes, based on their unique gene symbols. To calculate tissue specific enrichment, we used a moderated t-test implemented in limma 9 to identify differentially expressed genes. False discovery rates (FDRs) were then estimated for this gene list using the method of Benjamini and Hochberg. 10 All bioinformatics analyses were carried out using an R statistical environment (http://www.r-project.org).
The NCBI Gene Expression Omnibus accession number for all the microarray data reported in this paper is GSE32334.
Gene set analysis
To perform a comprehensive and unbiased gene set analysis, we utilized a large compendium of over 10,000 mouse specific gene sets comprising Gene Ontology terms, KEGG pathways, MouseCyc pathways, MGI mouse phenotype associated genes, FANTOM4 mouse tissue specific transcription factor gene sets, and other custom gene sets related to development, signaling pathways, and stem cell regulation ( Supplementary Table S1 ). Furthermore, we compiled gene sets for lens development, human cataract, and for control purposes, tooth development, human tooth agenesis, and human orofacial clefting ( Supplementary Table S2 ). For lens development genes, we used a recently curated a list of genes that are critically involved in the pre-placodal and placodal stages of lens development. 11 In addition, we compiled lists of non-syndromic and syndromic human cataract genes based on a high quality manual collection of all known human cataract associated genes, Cat-Map. 2 Tooth development genes, for comparative purposes, were those that cause abnormal tooth development in mouse and/or human models, based on the Mouse Genome Informatics (MGI) database (mammalian phenotype ID: MP:0000116).
Similarly, tooth agenesis and orofacial clefting gene lists were taken from a recent review, 12 with the addition of one new non-syndromic tooth agenesis gene: Wnt10a. 13 Full details of these gene sets are available in Supplementary Table S2 . We tested whether the 200 most highly ranked genes (with or without WB control) were enriched for each gene set independently using Fisher's exact test. The resulting p-values were Bonferroni corrected.
In situ hybridization
In situ hybridization experiments were performed as previously described. 14 
RESULTS
Gene expression profiling of the mouse embryonic lens
To construct the iSyTE database, we identified three critical time points in lens development, at E10.5, E11.5 and E12.5, as the lens transitions from the stage of lens placode invagination (E10.5) to that of lens vesicle formation and the onset of lens fiber cell differentiation (E12.5) ( Fig. 1 ). 11, 15 This developmental window conforms to when mouse orthologs of many human cataract genes are strongly expressed in the developing mouse lens. To ensure high quality microarray data, we isolated total RNA from manually micro-dissected mouse embryonic lenses at these stages in amounts sufficient to use a single step cDNA amplification protocol (see Methods). Using whole genome transcript profiling on Affymetrix Mouse Genome 430 2.0 microarrays, we generated a developmental profile of the mouse lens transcriptome over the specified developmental interval. The quality of the processed microarrays was assessed using various diagnostic plots, and no anomalies were found ( Supplementary Fig. S1 ).
Identification of lens-enriched genes
To identify genes with lens-enriched expression, we established an in silico subtraction approach by which lens microarray datasets are compared to a developmentally matched microarray dataset representing the whole embryonic body from which the ocular tissue was removed by microdissection, denoted "WB". This in silico subtraction involves ranking all genes based on t-statistic when tissue specific expression profiles are compared to WB profiles. We hypothesized that this control background dataset, which we denoted "WB" for "whole body minus eyes", represents an optimal averaged gene expression profile for a mixture of tissues, and that comparison of tissue-specific profiles against the WB control profile would facilitate identification of genes with lens-specific or lens-enriched expression. We anticipated that the resulting in silico subtracted mouse lens database would represent a useful tool to identify lensenriched genes with roles in lens biology, and with which to prioritize candidate genes within mapped cataract loci for mutational analysis. While exceptions exist, this is consistent with the hypothesis that tissue enriched gene expression more likely reflects a function for the gene in that tissue, than if a gene exhibits ubiquitous or widespread expression. The ranked lists of lens enriched genes are what we refer to as the iSyTE database.
We tested the utility of this approach to identify genes associated with lens development and human cataract by first identifying the gene sets that are enriched in the top 200 highly ranked genes (representing ~1% of total number of genes in the genome) -with or without WB control -using Fisher's exact test with Bonferroni corrected p-values. The top 200 highly ranked genes from the lens dataset with WB subtraction were highly enriched for gene sets for eye and lens biology, without being enriched for gene sets for miscellaneous housekeeping factors ( Fig.   2A ). We also identified the most highly enriched gene sets for the top 200 highly ranked genes from the lens dataset without WB subtraction, and found that they mainly consisted of ribosomal proteins. Therefore, the in silico subtraction method specifically identifies lens-enriched genesboth with high expression and low expression in the lens -while filtering out genes with high expression that are not lens-specific. We further found that the top 200 lens-enriched genes from the WB subtraction dataset consist mainly of genes associated with lens development, isolated or non-syndromic cataract, and interestingly, with syndromic cataract as well ( Fig. 2B , C; Supplementary Fig. S2 ). Analysis using different numbers of top lens-enriched genes (such as n=100, 300, 500 genes) produced similar results (data not shown).
iSyTE effectively identifies known and novel genes associated with cataract
To test the potential of iSyTE to identify cataract associated genes, we analyzed 24 (Table 1) . Moreover, the effectiveness of mutant gene identification remained high even when the highly lens-specific crystallin encoding genes were removed from the analysis. These data reflect the ability of iSyTE to identify genes that are expressed at relatively low levels, but that are highly enriched in the lens. This group includes the genes FOXE3, HSF4, MAF and PITX3
that encode transcription factors, as well as BSFP2, LIM2 and MIP that encode cytoskeletal proteins ( Table 2 ).
In addition to the identification of known cataract genes, iSyTE can also identify novel cataract genes. We successfully employed a preliminary version of iSyTE to identify the genes involved in two separate cataract cases. 16, 17 In the first case, the patient presented with bilateral, progressive cataracts with posterior lenticonus as the primary phenotype and carried the balanced paracentric inversion 46,XY,inv(9)(q22.33q34.11). 16 The iSyTE database identified TDRD7 as the most probable candidate among 110 genes within a 10 Mb interval around the q22.33
breakpoint. Subsequently, disruption and haploinsufficiency of TDRD7 in the patient was confirmed, and an additional independent 3 bp coding region deletion mutation in TDRD7 was identified in a consanguineous case. In the second case, we applied iSyTE to another independent case of human congenital cataract, in which a translocation breakpoint ostensibly responsible for the proband's phenotype was located within a relatively gene-poor genomic interval in which no gene was directly interrupted. 17 Nonetheless, iSyTE correctly identified PVRL3 as the gene responsible for the proband's cataract phenotype, most likely on the basis of a position effect, as subsequently proven by the analysis of multiple mouse Pvrl3 mutant alleles.
As yet another validation of iSyTE, we used section in situ analysis for several iSyTEidentified genes on mouse embryonic lens sections to confirm that some of the novel genes that iSyTE ranked as lens-enriched were indeed expressed in the expected fashion ( Fig. 3 ). This analysis demonstrated highly enriched lens expression of all eight of eight randomly chosen genes that were ranked within the top 250 lens-enriched genes, establishing the validity of the database (Fig. 3) . Moreover, human orthologs of two of these genes (SIPA1L3 and PTPRU) fall within or near mapped human cataract loci. 18, 19 Gje1 (previously known as: Gjf1; Fig. 3 ) has been recently identified as a novel cataract-associated gene in a mouse model. 20 Besides these eight relatively uncharacterized genes, evidence for lens enrichment and association with cataract in mouse models has also recently been documented for other iSyTE lens-enriched genes, e.g.
Aldh1a1. 21 These results further support the utility of iSyTE as a cataract gene prioritization resource.
We next sought to use iSyTE to predict promising candidate genes in mapped human cataract loci for which the gene involved has not been identified. We analyzed the latest version of the Cat-Map dataset 2 (latest update September 30, 2011) and identified 17 mapped cataract intervals for which a gene has not yet been assigned. We then used iSyTE to predict the most promising candidate genes in these loci. We provide the top candidate genes in each mapped interval based on their high lens-enrichment rank in iSyTE (Table 3 ; Supplementary Table 3 ).
Based on our result that 88% (21/24) of known cataract genes are within the top 2 candidate genes within a mapped interval, the gene list in Table 3 of iSYTE-predicted candidate cataract genes can potentially serve as a resource for identifying and prioritizing cataract associated candidate genes for sequencing.
Basis of the effectiveness of the subtraction strategy
To understand the basis for the effectiveness of the subtraction strategy in identifying genes of functional significance in lens development, we compared gene expression between the developing lens and WB control ( Table 2 ). As expected, dramatic differences for signal intensities of genes encoding crystallin proteins between the lens and WB control were observed.
However, genes with relatively low levels of expression in the lens microarray database, which otherwise would likely be ranked as low priority candidates (e.g., Hsf4, Bfsp2), are identified by the subtraction strategy; genes encoding developmental transcription factors also appear to be preferentially selected.
Lastly, the microarray expression patterns in the three developmental stages appears to faithfully reflect the published expression pattern of genes in lens development. For example, Bmp7, Meis1, Sox2, Pax6 and Mab21l1, which function in early lens development, have progressively decreased expression by microarray from E10.5 through E12.5. In contrast, Gja3, Gja8, Sox1, Prox1, Mip and Lim2, which function in lens fiber cells, have progressively increased expression by microarray from E10.5 through E12.5. Thus, because of its derivation from three temporally distinct stages of lens development, the iSyTE database provides insight into early or late function for the gene of interest.
Extension of the subtraction strategy to other tissue types
To investigate whether the in silico subtraction strategy could be generally applied to identify genes associated with other developmental disorders, we generated a microarray dataset for the developing molar tooth, which is a well-established system for studying the epithelialmesenchymal interactions involved in organogenesis. We performed laser capture microdissection (LCM) to capture mouse embryonic E13.5 tooth germ tissue and then extracted sufficient total RNA to perform microarrays after two rounds of in vitro transcription-based amplification (double amplification) ( Supplementary Fig. 3 ). Using the same amplification protocol, we also generated a microarray dataset from total RNA extracted and pooled in equimolar ratios from mouse whole body (WB) tissue at E11.5, E12.5 and E13.5. Similar to the lens, the tooth specific profiles were "subtracted" from the WB control using a moderated t-test and a tooth enrichment p-value was assigned to each gene. t-statistics were used to rank genes for tooth enrichment.
We next tested the utility of this strategy to identify genes associated with tooth development and human tooth and craniofacial defects. Similar to the lens, these analyses demonstrate that the top 200 highly ranked genes after WB subtraction were highly enriched for genes relevant to tooth biology, without being enriched for genes encoding miscellaneous house keeping factors ( Supplementary Fig. 4A ). As expected, the top 200 tooth-enriched genes from the WB subtraction dataset contained genes associated with syndromic and non-syndromic tooth agenesis and with orofacial clefting ( Supplementary Fig. 4B, C) . These data are accessible at:
http://bioinformatics.udel.edu/Research/iSyTE and indicate that in addition to the lens, the in silico subtraction strategy can successfully identify genes associated with tooth development and disease.
Use of WB microarray datasets as a public resource
We next sought to test the robustness and applicability of the two different WB datasets generated in this study. The two sets of WB microarray gene expression profiles generated in this study were generated by two experimentalists, using two different amplification protocols (single amplification for lens, and double amplification for tooth), and at slightly different developmental stages (E10.5, 11.5 and 12.5 for lens, and E11.5, 12.5 and 13.5 for tooth). We tested whether we could still identify tissue specific gene enrichment even when WB profiles were generated from a different preparation. Indeed, swapping the different WB profiles generated for the lens and the tooth analysis in the in silico subtraction strategy still robustly identified genes associated with lens and tooth developmental disorders, respectively (Fig. 4 ).
Construction of a web-based public resource: iSyTE
Finally, we sought to represent the lens enrichment data in user-friendly Genome Browser tracks, allowing our genome-wide lens enrichment data to be visualized in the context of the vast amount of genomic annotation that is already available. We created a custom iSyTE track at the University of California at Santa Cruz (UCSC) Genome Browser, and it is accessible from http://bioinformatics.udel.edu/Research/iSyTE. Each track is color-coded to represent the lensenrichment ranking based on WB-subtracted gene expression profiles of E10.5, E11.5 and E12.5 lens. Thus, iSyTE tracks allow the visualization of genes with their degree of enrichment of expression in the developing lens expressed in a color-coded format, with red being highly enriched and blue highly depleted (Fig. 5 ). To make our resource useful for a wide variety of users, we provide iSyTE custom tracks for two widely used human genome assemblies (hg19 and hg18), and two mouse genome assemblies (mm9 and mm8).
Operationally, after opening the UCSC Genome Browser for a specific genome assembly the user can search for and browse any genomic interval of interest. This representation allows immediate visual detection of the best candidate genes in a given genomic interval, and allows one to zoom in or out to visualize the presence of promising candidates within a particular region or proximal to it. The iSyTE tracks can be viewed in the context of other genomic resources that are already available in the UCSC Genome Browser, such as sequence conservation, known SNP locations, and ENCODE histone modification profiles. Lastly, visualization of the iSyTE tracks that represent three embryonic stages in one frame provides some appreciation of the dynamic pattern of gene expression during lens development.
DISCUSSION
Although it has been proposed that tissue-specific gene expression profiling may facilitate disease gene identification, 22, 23 and gene expression datasets for many tissue and cell types exist, the application of these resources to gene discovery, particularly in the context of disease, has been limited. 24 This is largely because such datasets are large and the route to efficient selection and prioritization of candidate genes is not straightforward, especially in the context of normal development and in the absence of clear control versus mutant gene expression change comparisons. Several gene expression atlases that are based on in situ hybridization provide insight into developmental gene expression, 25 but such information is typically non-quantitative and does not permit facile comparison of tissue specific gene expression levels. In this work, we developed a strategy to subject tissue-specific microarray datasets to an in silico subtraction that involve a comparison of a tissue specific dataset with a whole body ("WB") reference dataset, which allows the systematic ranking of genes based on their tissue enrichment. Even with high throughput sequencing, mutations that lie outside of coding regions may be difficult to identify.
We demonstrate that this filter provides a highly effective way to identify candidate genes associated with the development of specific tissues for which gene expression profiles can be readily obtained.
The development of iSyTE was based on two basic hypotheses: (1) genes that are highly expressed at critical stages of murine embryonic development in a specific organ are likely associated with mutations in human genes that are linked to an organ specific birth defect; and
(2) in silico subtraction of gene expression profiles for whole embryonic body from those for equivalently staged specific, microdissected embryonic tissue can effectively remove nonspecific but highly expressed genes, thereby revealing tissue specific genes. Using lens and
tooth as examples, we show that this relatively straightforward experimental and computational approach can effectively facilitate the identification of human disease-associated genes.
As with any gene prediction tool, there is a false negative rate associated with a given prediction, and it is important to consider the potential source of false negatives when interpreting results from iSyTE. Our retrospective analysis of 24 known cataract genes indicates that ~10% of the genes do not have high lens expression or enriched expression as measured in the current microarray data, hence suggesting a false negative rate of about 10%. This could potentially result from: (1) the sensitivity of the microarray probes for these genes may be poor;
(2) the expression of these genes may be restricted to a different developmental stage(s) than those analyzed; and (3) the effect of lens-specific expression is masked by neighboring genes within the candidate interval that have higher levels of lens-specific expression but which are non-causative.
Indeed, such examples are evident in our present data analysis. For example, in 3 cases out of 24 (FYCO1, GCNT2, CHMP4B), iSyTE did not rank the correct gene within the top 2 candidates in the interval (Table 1) . On further analysis, in case of FYCO1 (ranked 21/191), the mapped interval was large (12.21 Mb) containing 191 candidate genes, several of which exhibited significantly higher lens enriched expression than FYCO1. In case of GCNT2 (ranked 7/21 within a 5.26 Mb interval), we find very low expression of this gene in the microarrays, indicative of either sub-optimal probe binding or genuinely low expression at the lens stages analyzed. Lastly, in case of CHMP4B (ranked 34/43 in a 3.03 Mb mapped interval), this gene is significantly expressed in the lens (signal detection p < 0.002), but it is also significantly expressed in the WB control; as a result it does not have a high lens-enrichment rank, and is therefore not correctly identified by iSyTE as a likely candidate gene.
In some cases, iSyTE does not predict any promising candidate genes based on lensenrichment (e.g., in the mapped human cataract intervals on 2q33 and 17p24 ( Table 3) ). In yet another case (20p11.23-p12.1), iSyTE predicted BFSP1 from 29 candidates in the interval (Table   3 ). However, in this interval, BFSP1 has been sequenced and found to harboring no exonic or exon junction mutation, suggesting that the mutation resides in a regulatory region or in another gene. Therefore, in all cases, further experimental validation via mutational sequence analysis will be necessary in addition to the in silico predictions made by iSyTE.
Other genome-wide in silico analyses have recently been applied to the interpretation of candidate SNPs in genome-wide association studies (GWAS). 26 For example, Ernst and coworkers 27 showed that cell-type specific histone modification patterns can identify regulatory regions, and that knowledge of the location of these regulatory regions and their associated genes can aid in the interpretation of GWAS by providing potential regulatory mechanisms for each candidate SNP. Similarly, Ozkul and coworkers 28 was profiled using microarrays. Several hundred lenses at stages E10.5, E11.5 and E12.5 were pooled for generating total RNA for each biological replicate in microarrays conducted in triplicate. We also obtained the microarray gene expression profile for pooled whole embryonic body (WB) tissue at each stage; the ocular region was removed from the whole embryonic tissue before profiling. Lens-specific profiles are "subtracted" from the WB control using a moderated t-test. A lens enrichment p-value is assigned to each gene for each embryonic stage, and a False Discovery Rate (FDR) was calculated based on the p-value. t statistics were used to rank the genes for lens enrichment. The green color of the lenses represents fluorescence due to use of lens tissue carrying a Pax6P03.9-GFP reporter, included in pilot experiments as a quality control for the fidelity of lens collection (see Methods). Thus, the in silico subtraction strategy is robust against the use of different WB. This supports the idea that the WB generated in this study can be used as a public resource for comparison with gene expression profiles of other embryonic tissues at similar stages. 
